Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6LI6

Crystal structure of MCR-1-S treated by Au(PEt3)Cl

6LI6 の概要
エントリーDOI10.2210/pdb6li6/pdb
分子名称Probable phosphatidylethanolamine transferase Mcr-1, GOLD ION, TRIETHYLPHOSPHANE, ... (4 entities in total)
機能のキーワードmcr-1-s au(pet3)cl, antibiotic, transferase
由来する生物種Escherichia coli
タンパク質・核酸の鎖数2
化学式量合計75684.10
構造登録者
Zhang, Q.,Wang, M.,Sun, H. (登録日: 2019-12-10, 公開日: 2020-09-16, 最終更新日: 2024-10-16)
主引用文献Sun, H.,Zhang, Q.,Wang, R.,Wang, H.,Wong, Y.T.,Wang, M.,Hao, Q.,Yan, A.,Kao, R.Y.,Ho, P.L.,Li, H.
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin.
Nat Commun, 11:5263-5263, 2020
Cited by
PubMed Abstract: Global emergence of Gram-negative bacteria carrying the plasmid-borne resistance genes, bla and mcr, raises a significant challenge to the treatment of life-threatening infections by the antibiotics, carbapenem and colistin (COL). Here, we identify an antirheumatic drug, auranofin (AUR) as a dual inhibitor of metallo-β-lactamases (MBLs) and mobilized colistin resistance (MCRs), two resistance enzymes that have distinct structures and substrates. We demonstrate that AUR irreversibly abrogates both enzyme activity via the displacement of Zn(II) cofactors from their active sites. We further show that AUR synergizes with antibiotics on killing a broad spectrum of carbapenem and/or COL resistant bacterial strains, and slows down the development of β-lactam and COL resistance. Combination of AUR and COL rescues all mice infected by Escherichia coli co-expressing MCR-1 and New Delhi metallo-β-lactamase 5 (NDM-5). Our findings provide potential therapeutic strategy to combine AUR with antibiotics for combating superbugs co-producing MBLs and MCRs.
PubMed: 33067430
DOI: 10.1038/s41467-020-18939-y
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.68 Å)
構造検証レポート
Validation report summary of 6li6
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon